SE445294B - Forfarande for framstellning av en injicerbar suspension av membranvesiklar bestaende av celler fran blod - Google Patents

Forfarande for framstellning av en injicerbar suspension av membranvesiklar bestaende av celler fran blod

Info

Publication number
SE445294B
SE445294B SE7713944A SE7713944A SE445294B SE 445294 B SE445294 B SE 445294B SE 7713944 A SE7713944 A SE 7713944A SE 7713944 A SE7713944 A SE 7713944A SE 445294 B SE445294 B SE 445294B
Authority
SE
Sweden
Prior art keywords
vescells
membrane
preparing
procedure
blood cells
Prior art date
Application number
SE7713944A
Other languages
English (en)
Swedish (sv)
Other versions
SE7713944L (sv
Inventor
U Zimmermann
G Pilwat
K Bock
H-J Buers
Original Assignee
Kernforschungsanlage Juelich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kernforschungsanlage Juelich filed Critical Kernforschungsanlage Juelich
Publication of SE7713944L publication Critical patent/SE7713944L/xx
Publication of SE445294B publication Critical patent/SE445294B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
SE7713944A 1976-12-09 1977-12-08 Forfarande for framstellning av en injicerbar suspension av membranvesiklar bestaende av celler fran blod SE445294B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2655801A DE2655801C2 (de) 1976-12-09 1976-12-09 Injizierbare Suspension von Membranvesikeln aus Erythrozyten und Verfahren zur Herstellung der Suspension

Publications (2)

Publication Number Publication Date
SE7713944L SE7713944L (sv) 1978-06-10
SE445294B true SE445294B (sv) 1986-06-16

Family

ID=5995087

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7713944A SE445294B (sv) 1976-12-09 1977-12-08 Forfarande for framstellning av en injicerbar suspension av membranvesiklar bestaende av celler fran blod

Country Status (8)

Country Link
US (1) US4224313A (de)
JP (1) JPS5372890A (de)
CH (1) CH632927A5 (de)
DE (1) DE2655801C2 (de)
FR (1) FR2373289A1 (de)
GB (1) GB1560165A (de)
IL (1) IL53594A (de)
SE (1) SE445294B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2656746C2 (de) * 1976-12-15 1986-06-26 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verwendung von beladenen Erythrozyten
US4489162A (en) * 1981-12-21 1984-12-18 American Hospital Supply Corporation Fresh blood (unfixed) hematology control
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
US4478824A (en) * 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
US4610241A (en) * 1984-07-03 1986-09-09 Gordon Robert T Atherosclerosis treatment method
US4931276A (en) * 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
DE3812816A1 (de) * 1988-04-16 1989-11-02 Lawaczeck Ruediger Dipl Phys P Verfahren zur solubilisierung von liposomen und/oder biologischer membranen sowie deren verwendung
US4935223A (en) * 1988-08-04 1990-06-19 Board Of Regents, The University Of Texas System Labeled cells for use in imaging
US5116615A (en) * 1989-01-27 1992-05-26 Immunolytics, Inc. Method for treating benign prostatic hypertrophy
ATE121946T1 (de) 1989-01-27 1995-05-15 Immunolytics Inc Zusammensetzung und verfahren für die behandlung gutartiger prostata-hypertrophie.
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
WO1993018397A1 (en) * 1992-03-02 1993-09-16 Streck Laboratories, Inc. Reference control for use with manual and flow cytometric reticulocyte counting devices
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
US20020111461A1 (en) * 1999-05-21 2002-08-15 Todd C. Somers Low molecular weight peptidomimetic growth hormone secretagogues
DE69732225T2 (de) * 1997-05-05 2005-06-23 Dideco S.R.L., Mirandola Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
GB9917416D0 (de) * 1999-07-23 1999-09-22 Univ Ulster
US20040071664A1 (en) * 1999-07-23 2004-04-15 Gendel Limited Delivery of an agent
DE60026313D1 (de) 1999-07-23 2006-04-27 Uutech Ltd Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes
GB0002856D0 (en) * 2000-02-08 2000-03-29 Gendel Limited Ultrasound sensitisation
GB0025147D0 (en) * 2000-10-13 2000-11-29 Torsana Diabetes Diagnostics A Optical sensor for in situ measurement of analytes
WO2004112747A2 (en) * 2003-06-24 2004-12-29 Baxter International Inc. Specific delivery of drugs to the brain
US8986736B2 (en) * 2003-06-24 2015-03-24 Baxter International Inc. Method for delivering particulate drugs to tissues
CN1913871A (zh) * 2004-01-29 2007-02-14 巴克斯特国际公司 用于提高中枢神经系统投递的抗－逆转录病毒药剂的纳米悬浮液
BRPI0510271A (pt) * 2004-06-15 2007-10-30 Baxter Int aplicações ex-vivo agentes terapêuticos microparticulados
CN101965195A (zh) 2008-03-05 2011-02-02 巴克斯特国际公司 用于药物投送的组合物和方法
DE102008029172A1 (de) 2008-06-19 2009-12-24 Kenndoff, Jochen, Dr. Verfahren zum Schutz von insbesondere verletzten oder gestressten Hautbereichen einer Zitze während des Melkvorgangs
US10952965B2 (en) * 2009-05-15 2021-03-23 Baxter International Inc. Compositions and methods for drug delivery
IT1399590B1 (it) 2010-04-26 2013-04-26 Erydel Spa Apparato e kit per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti
ITBO20100256A1 (it) * 2010-04-26 2011-10-27 Erydel Spa Metodo per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti
FR3005420B1 (fr) * 2013-05-07 2015-09-18 Erytech Pharma Procede de stabilisation de suspensions d'erythrocytes encapsulant un principe actif, suspensions obtenues.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887698A (en) * 1973-03-12 1975-06-03 Univ Leland Stanford Junior Sacs with epitopic sites on walls enclosing stable free radicals
DE2326161C2 (de) * 1973-05-23 1986-07-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verfahren zum Aufbau oder zum Abbau von durch chemische Eigenschaften ausgezeichneten, in einer wäßrigen Lösung enthaltenen Stoffen
GB1481480A (en) * 1974-02-02 1977-07-27 Kernforschungsanlage Juelich Process and apparatus for increasing the permeability of the membrane of cells of organisms
DE2656746C2 (de) * 1976-12-15 1986-06-26 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verwendung von beladenen Erythrozyten

Also Published As

Publication number Publication date
SE7713944L (sv) 1978-06-10
CH632927A5 (de) 1982-11-15
DE2655801A1 (de) 1978-06-22
IL53594A (en) 1981-06-29
FR2373289A1 (fr) 1978-07-07
GB1560165A (en) 1980-01-30
FR2373289B1 (de) 1981-05-29
DE2655801C2 (de) 1986-06-26
JPS5372890A (en) 1978-06-28
US4224313A (en) 1980-09-23

Similar Documents

Publication Publication Date Title
SE445294B (sv) Forfarande for framstellning av en injicerbar suspension av membranvesiklar bestaende av celler fran blod
SE7801766L (sv) Forfarande for beredning av en suspension av celler
NO145915C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive karboksyalkylacylaminosyrer
NO150203C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive 4-hydroksy-2h-1,2-benzotiazin-3-karboksamid-1,1-dioksyder
NO149923C (no) Analogifremgangsmaate for fremstlling av fysiologisk aktive prolinderivater
NO149035C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
NO811121L (no) Fremgangsmaate for fremstilling av derivater av oktahydro-1h-indol-2-karboksylsyrer med antihypertensiv aktivitet
TR19755A (tr) Tereftalik asidin hazirlanmasina mahsus usul
NO854260L (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenylacetamido)) gruppeholdige cefalosporansyrederivater
NO151860C (no) Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
NO144220C (no) Fremgangsmaate for immobilisering av mikrobielle celler
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
SE7810731L (sv) Forfarande for tillverkning av elektrokemiska celler eller batterier
NO147913C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
SE421636B (sv) Forfarande for framstellning av kollagenfibrer
SE435712B (sv) Analogiforfarande for framstellning av 1-nitro-9-dialkylaminoisoalkylaminoakridiner eller salter derav
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
NO148039C (no) Fremgangsmaate til elektrolytisk fremstilling av elektrokjemisk aktivt, svovelholdig nikkel
SE436647B (sv) Forfarande for framstellning av prostaglandinderivat (prostacyclin)
SE7709547L (sv) Forfaringssett for framstellning av separatorer for elektrokemiska celler
NL174345C (nl) Zuur alkalicitraat, werkwijze ter bereiding daarvan en therapeutisch preparaat.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7713944-2

Effective date: 19880927

Format of ref document f/p: F